In8Bio (INAB) Treasury Shares (2020 - 2021)
In8Bio (INAB) posted Treasury Shares of $10.0 million for Q2 2021, little changed sequentially from $10.0 million in Q1 2021, and up 135.26% YoY from $4.2 million in Q2 2020.
In8Bio (INAB) Treasury Shares (2020 - 2021) Analysis & Trends
In8Bio has reported Treasury Shares for 2 years, with the latest figure at $10.0 million in Q2 2021.
- Quarterly Treasury Shares rose 135.26% year-over-year to $10.0 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $10.0 million (up 135.26% YoY) and the FY2020 annual result came in at $10.0 million, changed N/A from the prior year.
- Treasury Shares was little changed at $10.0 million in Q2 2021 per INAB's latest filing, from $10.0 million in the prior quarter.
- Over five years, Treasury Shares peaked at $10.0 million in Q4 2020 and troughed at $4.2 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.72 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 8.96 Mn |
| 10 | In8Bio | 22.97 Mn | 22.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 9.99 Mn |
| Jun 30, 2021 | 9.99 Mn |
| Mar 31, 2021 | 9.99 Mn |
| Mar 31, 2021 | 9.99 Mn |
| Dec 31, 2020 | 9.99 Mn |
| Dec 31, 2020 | 9.99 Mn |
| Sep 30, 2020 | 9.76 Mn |
| Sep 30, 2020 | 9.76 Mn |
| Jun 30, 2020 | 4.25 Mn |
| Jun 30, 2020 | 4.25 Mn |